Home » Newsletters » BioWorld Science

BioWorld Science

June 3, 2014

View Archived Issues

Combining GLP-1-expressing plasmids and DPP IV gene silencing for type 2 diabetes

An ultrasensitive noninvasive method for the detection of cancer biomarkers

Novel non-selective PDGFR inhibitor prevents the progression of PAH

Fullerene polyaminocaproic acid -- new potent anti-HIV drug candidate

GSK and Shionogi divulge new cephems

TP-271 shows efficacy in F. tularensis infection model

Ipsen Pharma synthesizes novel somatostatin receptor agonists

Preliminary phase I results presented for novel oligoclonal anti-EGFR antibody combination

Arena Pharmaceuticals and the University of Copenhagen prepare novel GPR119 receptor antagonists

Indian and Malaysian group present novel FabL inhibitors

Scientists at Roche disclose novel TRPA1 antagonists

Altor Bioscience to study ALT-803 in combination with BCG for bladder cancer

Aduro Biotech grants Janssen Biotech license to immunotherapies for prostate cancer

Collegium advances Hydrocodone DETERx program

Protea Biosciences and University of Southampton partner on Alzheimer's research

Shanghai Hutchison Pharmaceuticals joint venture gains rights to products in China

Arch Biopartners engages d3 Medicine to develop MetaMx for brain tumors

Memorial Sloan Kettering and Quest Diagnostics collaborate in precision medicine

Dilaforette reports phase I/II results on sevuparin in malaria

MPDL-3280A leads to rapid response in metastatic bladder cancer

Bristol-Myers Squibb designs novel IRAK-4 inhibitors

Cell Therapeutics changes name to CTI BioPharma

FDA approves Omidria for use in cataract and intraocular lens replacement procedures

Roche acquires Genia Technologies

Merrion Pharmaceuticals' GIPET technology advances with Novo Nordisk oral insulin development

FDA grants AZD-0914 fast track and QIDP designations

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...